Acridine Orange as a Novel Photosensitizer for Photodynamic Therapy in Glioblastoma.

Acridine Orange as a Novel Photosensitizer for Photodynamic Therapy in Glioblastoma.

World Neurosurg. 2018 Apr 06;:

Authors: Osman H, Elsahy D, Saadatzadeh MR, Pollok KE, Yocom S, Hattab E, Georges J, Cohen-Gadol AA

Abstract
OBJECT: Photodynamic therapy is an exciting treatment modality that combines the effects of a chemical agent with the physical energy from light or radiation to result in lysis of cells of interest. Acridine orange is a molecule with fluorescence properties that was demonstrated to possess photosensitizing properties. The objective of this study was to investigate the photodynamic effect of acridine orange on glioblastoma cell viability and growth.
METHODS: Glioblastoma cells (n = 8000 cells/well at 0 hours) were exposed to acridine orange followed by white unfiltered light-emitting diodes (LED) light. Cultures were exposed to either 10 or 30 minutes of light. The cell number per well was determined at 0, 24, 48, and 72 hours after exposure.
RESULTS: A dramatic cytocidal effect of acridine orange after exposure to as little as 10 minutes of white light was observed. There was almost complete eradication of the glioblastoma cells over a 72-hour period. Although acridine orange or light alone exhibited some effect on cell growth, it was not as pronounced as the combination of acridine orange and light.
CONCLUSIONS: This is the first study to demonstrate the photodynamic effect of acridine orange in glioblastoma cells. This data supports the need for further studies to characterize and evaluate whether this striking cytotoxic effect can be achieved in vivo. The combination of acridine orange and exposure to white unfiltered LED light may have potential future applications in management of glioblastoma.

PMID: 29631084 [PubMed - as supplied by publisher]

https://ift.tt/2qjyW2R